Irish Blood Transfusion Service

Procurement Intelligence

The Irish Blood Transfusion Service (IBTS) is the national statutory body responsible for collecting, testing, processing and supplying blood and blood products to more than seventy hospitals across the Republic of Ireland.[3][10] It operates the National Blood Centre in Dublin and regional centres, supporting clinical services such as transfusion medicine, stem cell and tissue services.[3][10] Procurement activity spans **laboratory and medical consumables**, specialist equipment and maintenance, ICT systems and support, facilities management, and a range of professional services needed to run highly regulated clinical operations.[1][8] 2023–2026 disclosed contract data indicates at least 30 awarded contracts worth about €11.1 million, suggesting a steady but moderate procurement scale relative to larger health bodies, with regular tenders for services like validation, calibration and IT support.[2][8]

Strategic Context

The current IBTS strategic plan ("Transforming Together" / People & Culture Statement of Strategy) for 2021–2025 focuses on service modernisation, developing new products and services, and strengthening organisational capability, which drives investment in technology, facilities and specialist support services.[4][9] The strategy highlights an expanding remit beyond traditional blood collection, including product development and enhanced clinical services, implying ongoing demand for high‑spec laboratory infrastructure, quality systems and digital solutions.[4] IBTS is also managing risks around supply resilience (including occasional import of blood components from other services) and regulatory compliance, which shapes timing and specifications of procurement, particularly for logistics, quality assurance and contingency arrangements.[1][4]

Updated 5 July 2026